VAERS reports by lot

GSK Varicella/Shingles lot 453S4: VAERS reports

32 VAERS reports list lot 453S4 as a GSK Varicella/Shingles vaccine, received between 2020-01-05 and 2024-08-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
32
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2728%
General / Systemic (non-local)1819%
Musculoskeletal1212%
Dermatological (non-injection-site)1111%
Neurological77%
Cardiac / Cardiovascular77%
Gastrointestinal77%
Allergic / Anaphylactic66%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania4
Ohio4
California3
Alabama3
Texas2
Indiana2
Massachusetts2
Tennessee1
Florida1
New York1
District of Columbia1
Virginia1

Reports by month received

2020-019
2020-028
2020-032
2020-051
2020-062
2020-072
2020-081
2020-092
2020-103
2021-011
2024-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.